Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gejun Zhang

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Oncology Reports|August 15, 2018
Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing studyQingzhuo Dong, Chengcheng Lv, Gejun Zhang, et al.
Cancer Cell International|February 13, 2025
An online clustering algorithm predicting model for prostate cancer based on PHI-related variables and PI-RADS in different PSA populationsJiyuan Hu, Qi Miao, Jiayi Ren, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2019
PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathwayChengcheng Lv, Shui Fu, Qingzhuo Dong, et al.
Cancer Gene Therapy|November 22, 2018
ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathwayGejun Zhang, Zi Yu, Shui Fu, et al.
The American Journal of the Medical Sciences|March 21, 2017
Outcomes of Percutaneous Closure of Patent Ductus Arteriosus Accompanied With Unilateral Absence of Pulmonary ArteryYankun Yang, Hong Zheng, Zhongying Xu, et al.
International Journal of Oncology|June 11, 2019
PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathwaysZi Yu, Qiang Li, Gejun Zhang, et al.
Cancer Gene Therapy|January 28, 2022
Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathwayGejun Zhang, Zi Yu, Shui Fu, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 15, 2023
Outcomes following transcatheter closure or surgical repair of coronary-left ventricular fistula: A single-center study with 10-year experienceYihang Li, Peijian Wei, Zhongying Xu, et al.
Scientific Reports|December 29, 2024
Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patientsXianlu Zhang, Jiyuan Hu, Haoyuan Zheng, et al.
The American Journal of the Medical Sciences|September 22, 2016
Simultaneous Transcatheter Closure of Multiple Atrial Septal Defects Using Dual Amplatzer Septal Occluder DevicesYankun Yang, Zhongying Xu, Shiliang Jiang, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Oncology Reports|August 15, 2018
Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing studyQingzhuo Dong, Chengcheng Lv, Gejun Zhang, et al.
Cancer Cell International|February 13, 2025
An online clustering algorithm predicting model for prostate cancer based on PHI-related variables and PI-RADS in different PSA populationsJiyuan Hu, Qi Miao, Jiayi Ren, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2019
PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathwayChengcheng Lv, Shui Fu, Qingzhuo Dong, et al.
Cancer Gene Therapy|November 22, 2018
ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathwayGejun Zhang, Zi Yu, Shui Fu, et al.
The American Journal of the Medical Sciences|March 21, 2017
Outcomes of Percutaneous Closure of Patent Ductus Arteriosus Accompanied With Unilateral Absence of Pulmonary ArteryYankun Yang, Hong Zheng, Zhongying Xu, et al.
International Journal of Oncology|June 11, 2019
PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathwaysZi Yu, Qiang Li, Gejun Zhang, et al.
Cancer Gene Therapy|January 28, 2022
Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathwayGejun Zhang, Zi Yu, Shui Fu, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 15, 2023
Outcomes following transcatheter closure or surgical repair of coronary-left ventricular fistula: A single-center study with 10-year experienceYihang Li, Peijian Wei, Zhongying Xu, et al.
Scientific Reports|December 29, 2024
Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patientsXianlu Zhang, Jiyuan Hu, Haoyuan Zheng, et al.
The American Journal of the Medical Sciences|September 22, 2016
Simultaneous Transcatheter Closure of Multiple Atrial Septal Defects Using Dual Amplatzer Septal Occluder DevicesYankun Yang, Zhongying Xu, Shiliang Jiang, et al.
Pageof 6